01938nas a2200385   4500000000100000008004100001260001600042653001600058653002200074653001200096653002200108653002200130653001100152653001600163653002300179653002400202653002500226653000900251653001600260653002500276653001300301653002100314653001600335100001100351700001500362700001600377700001300393245006100406856006600467300000600533490000700539050001400546520097800560022001401538       2013                            d  c2013 Apr 1510aClofazimine10aContraindications10aDapsone10aDelayed Diagnosis10aDiagnostic Errors10aHumans10aHypesthesia10aLeprostatic Agents10aLeprosy, Borderline10aLeprosy, lepromatous10aMale10aMinocycline10aMycobacterium leprae10aRifampin10aTinea Versicolor10aYoung Adult1 aYang S1 aMakredes M1 aO'Donnell P1 aLevin NA00aA case of Hansen Disease presenting as tinea versicolor.  uhttp://anagen.ucdavis.edu/1904/02_csp/7_12-00277/article.html  a70 v19  aYANG 20133 a<p>Hansen Disease (leprosy) is an infectious disease that targets macrophages and Schwann cells, caused by the acid fast intracellular organism, Mycobacterium leprae. Clinically, it presents with a spectrum of findings that may include hypopigmented macules, erythematous plaques and nodules, and thickened or tender peripheral nerves. The most feared complication is mutilating damage to facial structures or digits resulting from loss of sensation in affected skin. In non-endemic areas, the diagnosis of leprosy is frequently delayed because it may mimic other more common skin conditions. We present a case of borderline/lepromatous leprosy in an otherwise healthy young Brazilian man that was initially diagnosed as tinea versicolor, but did not respond to appropriate treatment. This case highlights the importance of having a high index of suspicion for leprosy in patients from endemic areas who present with lesions that could be consistent with this disease. </p>  a1087-2108